Trademark: 86297568
Status Date
Friday, September 22, 2023
Registration Number
5047640
Registration Date
Tuesday, September 27, 2016
Filing Date
Monday, June 2, 2014
Published for Opposition
Tuesday, July 12, 2016
5 Diagnostic agents for medical purposes, diagnostic preparations for medical purposes, and pharmaceutical, veterinary and medical preparations for the treatment of malignant or benign tumor diseases, [ cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases ] containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles comprising iron oxide; pharmaceutical preparations containing metallic or magnetic particles in the nature of nanoparticles for use as anticarcinogenic agents and/or antineoplastic agents, and for treating malignant or benign tumor diseases, [ cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases ] ; contrasting agents for diagnostic imaging for medical purposes; none of the foregoing to be used with radiotherapy for cancer treatment
1 Chemical products, namely, magnetic nanoparticles composed of iron oxide for use in industry and research; chemical metallic or magnetic particles and nanometer particles for use in industry and research; biopolymers containing metallic nanoparticles for use in industry and research; synthetic and natural oxides in the form of granules and granulates containing iron oxide, in particular magnetite and maghemite; chemical products in the form of magnetic nanoparticles, namely, superparamagnetic nanoparticles and superparamagnetic iron oxide nanoparticles for use in industry and research; chemical preparations in the form of biocompatible polymer nanoparticles, liposomes, coated nanoparticles, and drug-containing nanoparticles, all of the foregoing for use in industry and research, namely, for use in therapy methods, thermotherapy methods, thermoablation methods and/or hyperthermia methods, but not including radiotherapy methods
44 Medical services, namely, cancer [ and cardiovascular ] therapy, cancer [ and cardiovascular ] treatment, and medical diagnosis of cancer [ and cardiovascular ] diseases in the nature of dispensing of medical diagnostics and pharmaceutical and medical preparations containing magnetic particles; conducting medical device-based therapeutic or diagnostic methods, namely, providing physical therapy using magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide; medical services, namely, treatment of malignant or benign tumor diseases, [ cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases ] ; medical services, namely, thermotherapeutic services, thermoablation methods and/or hyperthermia methods for cancer [ and cardiovascular ] treatment using magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles; providing medical testing for diagnostic or treatment purposes in the field of cancer [ and cardiovascular ] treatment; none of the foregoing services comprising radiotherapy in cancer treatment
10 [ Medical devices containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide, magnetic powders, granules, and granulates containing iron oxide for use in thermotherapy methods, thermoablation methods and/or hyperthermia methods, and none of the foregoing devices comprising compression equipment systems or apparatus or equipment for radiotherapy ]
42 Medical and scientific research in the field of cancer [ and/or cardiovascular treatment ] and diagnosis; development and design of medical devices containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide, all for treatment and/or diagnosis of cancer [ and/or cardiovascular diseases ] ; providing medical testing and information in the field of cancer [ and cardiovascular ] research; none of the foregoing services comprising radiotherapy in cancer treatment
In the statement, line 16, "302014044512" should be deleted, and "302014046512" should be inserted.
Sep 22, 2023
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Sep 22, 2023
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Sep 22, 2023
Case Assigned To Post Registration Paralegal
Mar 22, 2023
Teas Section 8 & 15 Received
Sep 27, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 30, 2017
Correction Under Section 7 ¿ Processed
Jan 30, 2017
Case Assigned To Post Registration Paralegal
Oct 14, 2016
Teas Section 7 Request Received
Sep 27, 2016
Registered-Principal Register
Jul 12, 2016
Official Gazette Publication Confirmation E-Mailed
Jul 12, 2016
Published For Opposition
Jun 22, 2016
Notification Of Notice Of Publication E-Mailed
Jun 7, 2016
Law Office Publication Review Completed
May 31, 2016
Approved For Pub - Principal Register
May 10, 2016
Teas/Email Correspondence Entered
May 9, 2016
Correspondence Received In Law Office
May 9, 2016
Teas Response To Office Action Received
Nov 9, 2015
Notification Of Non-Final Action E-Mailed
Nov 9, 2015
Non-Final Action E-Mailed
Nov 9, 2015
Non-Final Action Written
Oct 16, 2015
Teas/Email Correspondence Entered
Oct 16, 2015
Correspondence Received In Law Office
Oct 16, 2015
Teas Response To Office Action Received
Apr 17, 2015
Notification Of Non-Final Action E-Mailed
Apr 17, 2015
Non-Final Action E-Mailed
Apr 17, 2015
Non-Final Action Written
Mar 26, 2015
Teas/Email Correspondence Entered
Mar 26, 2015
Correspondence Received In Law Office
Mar 24, 2015
Assigned To Lie
Mar 13, 2015
Teas Response To Office Action Received
Sep 15, 2014
Notification Of Non-Final Action E-Mailed
Sep 15, 2014
Non-Final Action E-Mailed
Sep 15, 2014
Non-Final Action Written
Sep 15, 2014
Assigned To Examiner
Jun 13, 2014
New Application Office Supplied Data Entered
Jun 5, 2014
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
